Yes, I did. Tone was positive but not rah rah. Expect 11.5 mil. revenue from gov't agency contract alone next qtr. They did not give a revenue projection for next qtr but JMO it looks like another one like this one, maybe better with flu season really kicking in. Talked about the Iowa and California opportunities. Also said they has spent the last 2 years setting up the infrastructure for the business and gross margins will be very high from now on. Talked about this being an industry that they they created and they believe it to be a combined 2 billion industry that they have only penetrated by 1 per cent. They wouldn't or couldn't give specific revenue projections for the future other than the gov't agency contract which seemed to irritate a couple of callers.

My opinion here. This is a very compelling company. No debt (none), 13 mil cash on hand and growing, low number of shares outstanding, an untapped market in which they stand alone (for now), no analyst coverage, only about 5 % institutional ownership.

Some of the positives are also negatives short term IMO. No, or low analyst coverage means it is flying under the radar and thinly traded. Low institutional holdings means few long term holders but rather traders who jump on every opportunity to take a profit. There is also uncertainty because no one has a feel for this industry. SMED created it and is just beginning to exploit it.

Personally, I like this stock but make up your own mind.